Most Biel shareholders are comforted by knowing the direction the company is taking. Some of the guesswork has finally been taken out of the equation with the information recently communicated by Chairman Staelin. Let's face it...Actipatch has never received the attention it deserves...but that looks to be changing... and rapidly. We could be witnessing history in the pain management arena...Actipatch could literally be that good!
News 
Market Data 
Discover 
